Combination of | |
---|---|
Lamivudine | nucleoside reverse transcriptase inhibitor |
Nevirapine | non-nucleoside reverse transcriptase inhibitor |
Stavudine | nucleoside reverse transcriptase inhibitor |
Clinical data | |
Trade names | Triomune, others |
ATC code | |
Identifiers | |
CAS Number | |
ChemSpider |
|
Lamivudine/nevirapine/stavudine (3TC/NVP/d4T) is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS.[1] It contains lamivudine, nevirapine, and stavudine.[1] It is either used by itself or along with other antiretrovirals.[1] It is taken by mouth twice a day.[1]
It is on the World Health Organization's List of Essential Medicines.[2] As of 2015, it is not commercially available in the United States.[3]